WBA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Walgreens Boots Alliance, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Lawsuit Overview - The law firm Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Walgreens Boots Alliance Inc (WBA) for alleged violations of the Securities Exchange Act of 1934 [1] - The class period for the lawsuit is between October 12 2023 and June 26 2024 with the deadline for lead plaintiff motions set for September 10 2024 [1] Allegations Against Walgreens - The lawsuit alleges that Walgreens made false and/or misleading statements during the class period [2] - Defendants allegedly created a false impression of reliable information regarding Walgreens' projected revenue outlook and growth while minimizing risks from seasonality and macroeconomic fluctuations [2] - Walgreens' pharmacy division was not equipped to handle industry challenges and required significant restructuring for sustainability [2] Financial Impact - On June 27 2024 Walgreens announced Q3 2024 results below expectations and lowered FY 2024 projections [3] - Walgreens' CEO cited a difficult operating environment including persistent pressures on US consumers and eroded pharmacy margins [3] - Following the announcement Walgreens' stock price fell more than 22% [3] Lead Plaintiff Process - Investors who purchased or acquired Walgreens securities during the class period can seek appointment as lead plaintiff [4] - The lead plaintiff represents all class members and selects the law firm to litigate the case [4] - Serving as lead plaintiff is not a requirement for sharing in any potential future recovery [4]